Eli Lilly ‘Ghostwrote’ Articles to Market Zyprexa, Files Show

---

Wednesday June 24, 2009 | No Comments

This article from Bloomberg is a good reminder about validity of peer-review data and helps to put perspective on corporate involvement in ghostwriting activities. There is a lot of buzz about this topic in the consumer media recently.

by admin

ShareThis